Detalles de la búsqueda
1.
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Lancet
; 402(10395): 41-53, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331369
2.
Cetuximab every 2 weeks versus standard weekly dosing administration schedule.
Future Oncol
; 20(7): 393-407, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850363
3.
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
Oncologist
; 28(12): e1209-e1218, 2023 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37597246
4.
Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
Eur Radiol
; 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935847
5.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34807464
6.
Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma.
Oncologist
; 27(6): 430-e433, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675633
7.
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Oncologist
; 27(2): e194-e198, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35641218
8.
Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.
Br J Cancer
; 124(4): 721-727, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33235314
9.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30982686
10.
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment.
Invest New Drugs
; 38(6): 1774-1783, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410080
11.
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]. / Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom Interdisziplinäre Empfehlungen.
Z Gastroenterol
; 58(6): 577-582, 2020 Jun.
Artículo
en Alemán
| MEDLINE | ID: mdl-32544967
12.
[What does the nonradiologist expect from the radiologist?] / Was erwartet der Nichtradiologe vom Radiologen?
Radiologe
; 60(5): 421-429, 2020 May.
Artículo
en Alemán
| MEDLINE | ID: mdl-32052117
13.
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Cancer
; 125(18): 3208-3218, 2019 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31246283
14.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
N Engl J Med
; 375(19): 1856-1867, 2016 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27718784
15.
[Immuno-oncology of head and neck tumors]. / Immunonkologie von Kopf-Hals-Tumoren.
HNO
; 67(3): 221-235, 2019 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-30635676
16.
CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Oncologist
; 23(9): 1079-1082, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866947
17.
Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
BMC Cancer
; 18(1): 1124, 2018 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30445951
18.
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Lancet Oncol
; 18(8): 1104-1115, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28651929
19.
Buparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Oncol
; 18(3): 323-335, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28131786
20.
Comprehensive biomarker diagnostics of unfavorable cancer of unknown primary to identify patients eligible for precision medical therapies.
Eur J Cancer
; 200: 113540, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316065